Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arthritis & Rheumatism

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22168PMID 17075881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.

  2006cited by this paper
• Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.

  2005cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

  2005cited by this paper
• Treatment of hepatitis C virus-related systemic vasculitis.

  2005cited by this paper
• Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.

  2004cited by this paper
• Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.

  2004cited by this paper
• Longterm Efficacy of Interferon- α for Extrahepatic Disease Associated with Hepatitis C Virus Infection

  2004cited by this paper
• Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

  2004cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

  2003cited by this paper
• Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.

  2003cited by this paper
• Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.

  2003cited by this paper
• Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases

  2003cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

  2002cited by this paper
• Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis

  2001cited by this paper
• Systemic vasculitis in patients with hepatitis C.

  2001cited by this paper
• Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.

  2000cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.

  1997cited by this paper
• Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis.

  1995cited by this paper
• Guidelines for the management of essential mixed cryoglobulinemia.

  1995cited by this paper
• Testing the fit of a regression model via score tests in random effects models.

  1995cited by this paper
• Testing the fit of a regression model via score tests in random effects models.

  1995cited by this paper
• Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.

  1994cited by this paper
• Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.

  1993cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha.

  1993cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

  1993cited by this paper
• Characterization of cryoglobulins by immunoblotting.

  1992cited by this paper
• Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

  1980cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Biologic and clinical significance of cryoglobulins. A report of 86 cases.

  1974cited by this paper
• Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

  1966cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis

  2025cites this paper
• Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach

  2025influential citation
• A comparative study of different antiviral treatment protocols in HCV related cryoglobulinemic vasculitis

  2024cites this paper
• Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients

  2024cites this paper
• Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy

  2024cites this paper
• Rapidly Progressive Glomerulonephritis.

  2024cites this paper
• Extrahepatic manifestations of HCV where do we stand?

  2023cites this paper
• Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice

  2023cites this paper
• Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients

  2022cites this paper
• KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

  2022cites this paper
• Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

  2022cites this paper
• Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals

  2022cites this paper
• Progress in hepatitis C virus management in chronic kidney disease

  2021cites this paper
• Evolution of HCV-Associated Cryoglobulinemic Vasculitis after Treatment with Direct-Acting Antivirals

  2021cites this paper
• It Is Just a Rash They Said! Acute Skin Manifestation in a Patient With Vasculitis in Rural Hospitals

  2020cites this paper
• Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy

  2020cites this paper
• Sofosbuvir induced leucocytoclasic vasculitis: a case report

  2019cites this paper
• Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

  2019cites this paper
• Extrahepatic Manifestations of Hepatitis C Virus Infection

  2019cites this paper
• Glomerular Diseases Associated with Hepatitis B and C Infection, Adult

  2019cites this paper
• Hepatitis Arthritis: HBV and HCV

  2019cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2019cites this paper
• Long‐term Efficacy of Interferon‐Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

  2019cites this paper
• Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease

  2018cites this paper
• Efficacy and safety of sofosbuvir-based, interferon-free therapy

  2018cites this paper
• Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis

  2018cites this paper
• Autoimmune Kidney Diseases Associated with Chronic Viral Infections.

  2018cites this paper
• 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

  2018cites this paper
• Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens

  2018cites this paper
• Treatment of Pulmonary Vasculitis

  2018cites this paper
• Retreatment of symptomatic hepatitis C virus genotype 3 associated mixed cryoglobulinemia with sofosbuvir and ribavirin: a case report

  2018cites this paper
• Management of hepatitis B and C infections in rheumatologic disease.

  2018cites this paper
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

  2018cites this paper
• Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis

  2018cites this paper
• Considering hepatitis C virus infection as a systemic disease

  2018cites this paper
• Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase

  2018cites this paper
• Treatment of Extrahepatic Manifestations of Hepatitis C Virus.

  2017cites this paper
• International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

  2017cites this paper
• Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

  2017influential citation
• From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?

  2017cites this paper
• Efficacy and safety of sofosbuvir-based, interferon-free therapy A. A. Shahin, H. S. Zayed, M. Said & S. A. Amer

  2017cites this paper
• Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.

  2017cites this paper
• Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia

  2017cites this paper
• The efficiency of treatment of cryoglobulinemic vasculitis associated with hepatitis C virus: analysis of 60cases

  2017cites this paper
• Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon‐based to direct‐acting antivirals era

  2017cites this paper
• Inhibition of cryoglobulin synthesis as an effective method of positive influence on spermogram indices

  2017cites this paper
• Global epidemiology and burden of HCV infection and HCV-related disease

  2017cites this paper
• Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia.

  2017cites this paper
• Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.

  2017cites this paper
• Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.

  2017cites this paper
• Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus–Associated Cryoglobulinemia Treated With Direct‐Acting Antivirals

  2017cites this paper
• Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon‐based to direct‐acting antivirals era

  2017cites this paper
• Chapter 90 – Polyarteritis Nodosa and Related Disorders

  2017cites this paper
• Inhibition of cryoglobulin synthesis as a method of positive influence on spermogram indices (clinical observations)

  2017cites this paper
• [Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment].

  2017cites this paper
• Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

  2017cites this paper
• Dermatologic Manifestations of Chronic Hepatitis C Infection.

  2017cites this paper
• Treatment of HCV-Related Mixed Cryoglobulinemia.

  2017cites this paper
• Hepatitis C virus and its cutaneous manifestations: treatment in the direct‐acting antiviral era

  2017cites this paper
• Rheumatologic Manifestations of Hepatitis C Virus Infection.

  2017cites this paper
• Hepatitis C Therapy in Renal Patients: Who, How, When?

  2016cites this paper
• Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.

  2016cites this paper
• A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis

  2016cites this paper
• Hepatit is C Virus Infection and Rheumatic Diseases The Impact of Direct-Acting Antiviral Agents

  2016cites this paper
• Systemic manifestations of hepatitis C infection

  2016cites this paper
• Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug

  2016cites this paper
• [Chronic hepatitis C virus infection: An internist's opinion (Part 1)].

  2016cites this paper
• EXTRA-HEPATIC INVOLVEMENT IN CHRONIC LIVER DISEASES Brain: Looking beyond

  2016influential citation
• Extrahepatic manifestations of chronic hepatitis C virus infection

  2016cites this paper
• Current Treatment of Cryoglobulinemic Vasculitis

  2016cites this paper
• KASL clinical practice guidelines: management of hepatitis C

  2016cites this paper
• Cryoglobulins and Cryoglobulinemia

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.

  2016cites this paper
• SP0040 New Antivirals for Extrahepatic Manifestations of Hepatitis C Virus: The Model of Mixed Cryoglobulinemia Vasculitis

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Autoimmune-mediated peripheral neuropathies and autoimmune pain.

  2016cites this paper
• Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents

  2016cites this paper
• Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy

  2016cites this paper
• Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence

  2016cites this paper
• New insights into HCV-related rheumatologic disorders: A review

  2016cites this paper
• Impact of Extrahepatic Manifestations HCV Infection Increases Extrahepatic Mortality Antiviral Treatment Improves Extrahepatic Disease Outcomes Treatment of EHM with Antiviral Therapy May Be Curative Efficacy and Safety of DAA when Treating Symptomatic Mixed Cryoglobulinemia KEY TAKEAWAYS Program Di

  2016cites this paper
• Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients

  2016cites this paper
• The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review

  2016cites this paper
• HCV and the kidney

  2016cites this paper
• Vasculitic Neuropathies

  2015cites this paper
• [Cryoglobulinemic vasculitis with renal involvement: A historic aspect of the problem].

  2015cites this paper
• Hepatitis C and kidney disease: An overview and approach to management.

  2015cites this paper
• Vasculitis related to viral and other microbial agents.

  2015cites this paper
• HCV Treatments and Their Integration Into Rheumatology

  2015cites this paper
• Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study

  2015cites this paper
• Extrahepatic manifestations in chronic hepatitis C virus carriers

  2015cites this paper
• Administration of Intradermal Autoleukocyte Immunization as a Reduction Method of Cryoglobulin Synthesis in Patients with Chronic Hepatitis C

  2015cites this paper
• Treatment of Special Populations with Hepatitis C Virus Infection: Chronic Kidney Disease

  2015cites this paper
• Hepatitis C virus syndrome : A constellation

  2015cites this paper
• Cryoglobulinemia Vasculitis.

  2015cites this paper
• Treatment of hepatitis C-related kidney disease

  2015cites this paper
• Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

  2015cites this paper
• Updates on Clinical Features and Treatment Advances

  2015cites this paper
• Short and Long-Term Effects of Telaprevir on Kidney Function in Patients with Hepatitis C Virus Infection: A Retrospective Cohort Study

  2015cites this paper